Feedback / Questions
Undisclosed brain penetrant TRPML1 agonist - Lysoway Therapeutics
https://www.businesswire.com/news/home/20250805132586/en/Lysoway-Therapeutics-Awarded-Grant-from-The-Michael-J.-Fox-Foundation-to-Advance-TRPML1-Agonist-to-Treat-Parkinsons-Disease
 
Aug 5, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious